NanoViricides, Inc. (NYSE American: NNVC) presented its latest advancements at the MicroCap <a target=_blank href= ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

The global coronavirus therapeutics market is projected to exceed $16 billion by 2031. With its patented sublingual interferon technology, Ainos is poised to redefine antiviral treatment standards, ...

Ermenegildo Zegna N.V. (the "Company" and, together with its consolidated subsidiaries, the "Ermenegildo Zegna Group" or the "Group") today announced unaudited revenues of ?1,946.6 million for fiscal ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

Dec. 17, 2024 — Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an ... Single Mutation in H5N1 ...

Pandemics threaten both human health and the global economy. Vaccines are an essential part of the fight against pandemics, but they are only available months after the outbreak ...

He’s been widely quoted – and misquoted. People across the ideological spectrum have claimed Bonhoeffer would support their side on issues ranging from the Vietnam War to post-9/11 militarism ...

Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll BOSTON, MASSACHUSETTS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ...

Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFSThe ...